ACMT Position Statement: Interpretation of Urine for Tetrahydrocannabinol Metabolites

J Med Toxicol. 2020 Apr;16(2):240-242. doi: 10.1007/s13181-019-00753-8. Epub 2020 Jan 14.

Authors

Nicholas Connors^{1

2}, Michael J Kosnett³, Ken Kulig⁴, Lewis S Nelson⁵, Andrew I Stolbach⁶

Affiliations

¹ Department of Emergency Medicine, Medical University of South Carolina, Charleston, SC, USA.
² Palmetto Poison Center, Columbia, SC, USA.
³ University of Colorado School of Medicine, Aurora, CO, USA.
⁴ Toxicology Associates, Prof LLC, Denver, CO, USA.
⁵ Rutgers New Jersey Medical School, Newark, NJ, USA.
⁶ Johns Hopkins University School of Medicine, Baltimore, MD, USA. positionstatements@acmt.net.

No abstract available

Keywords: Cannabidiol; Cannabinoid; Drug testing; THC; Urine tox screen.

Publication types

Practice Guideline

MeSH terms

Biomarkers / urine
Biotransformation
Dronabinol / urine*
Humans
Marijuana Abuse / diagnosis*
Marijuana Abuse / urine
Predictive Value of Tests
Reproducibility of Results
Substance Abuse Detection / standards*
Urinalysis / standards

Substances

Biomarkers
Dronabinol